Assessment of Immunological Biomarkers in the First Year after Heart Transplantation
Table 1
Overview about demographic data and transplantation history. Data are presented for the whole study population (row 2) and according to the appearance of rejection within the first year after HTx (rows 3 and 4).
Whole population
Patients without rejection in the first year after HTx
Patients with rejection within the first 3 months after HTx
46
37
6
Age at HTx (±SD)
50.6 ± 12.5 yrs
50.5 ± 12.8 yrs
48.3 ± 11.3 yrs
Female gender (%)
(28%)
(35%)
(17%)
Disease leading to HTx
DCM
ICM
Other
Assist device support before HTx
Re-HTx
Death within the first year after HTx
Panel reactive antigen before HTx
PRA = 0
PRA > 0, <20
PRA ≥ 20
Transplant rejection (histopathological EMB grade ≤ grade IB or higher)
